Developer docs
API playgroundTry for free, no card

Search company profiles

Naru Intelligence

Full company profile

uuid000a6du

Namestring
Naru Intelligence
Legal namestring
NARU INTELLIGENCE SOLUTIONS S.L.
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Naru Intelligence Solutions S.L. is a Spanish healthtech software company founded in 2016 and headquartered in Donostia-San Sebastián, operating with 11–50 employees. The company builds software and connected data infrastructure for clinical research, with two interlocking business lines: prospective ePRO (electronic Patient-Reported Outcomes) tools for clinical trials and observational studies, and retrospective Real-World Evidence (RWE) generation through a network of European hospitals. Its core products include Step PROMs (a real-time ePRO data collection platform), Step Oncology (a specialized oncology platform integrating patient monitoring, a prescription mobile app, evidence generation, and analytics), Step Proactive (a CE-marked patient monitoring medical device), and RWEvolution (a multi-center European program generating oncology RWE through a shared technology framework across partner hospitals).

The company targets three primary customer segments: pharmaceutical sponsors running clinical trials, Contract Research Organizations (CROs), and hospitals and oncology centers participating in the RWEvolution network. Revenue mechanics are subscription/recurring-based, delivered through a quote-based B2B sales model with no publicly disclosed pricing. Naru differentiates on data quality and adherence — reporting 96% patient adherence to ePRO questionnaires, 98% on-time completion, and 24 months of sustained adherence — alongside its CE-marked monitoring device and continuous data capture from the point of origin.

The business model relies on direct sales engagement and is regionally concentrated in Spain and broader Europe. Capital structure is private (Sociedad Limitada), supported by non-dilutive public funding including HAZITEK R&D grants (co-financed by Gobierno Vasco and FEDER 2021–2027), CDTI Innovación's Innvierte co-investment program, and ENISA innovation financing. No private venture funding rounds or revenue figures are disclosed in available sources.

Short descriptiontext

Naru Intelligence is a Spanish healthtech software company building ePRO and Real-World Evidence platforms for pharmaceutical sponsors, CROs, and European hospitals, with core offerings including Step PROMs, Step Oncology, Step Proactive (CE-marked), and the RWEvolution multi-center oncology network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDonostia-san Sebastián, Spain
HQ citystring
Donostia-san Sebastián
HQ countrystring
Spain
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial ePRO software, patient-reported outcomes platform, real-world evidence generation, oncology clinical data capture, digital health technology
Industry3 codes
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code2 codes
  • Software Publishers513210
  • Other Scientific and Technical Consulting Services541690
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Processing & Data Preparation7374
Product category
Clinical Trial Technology / ePRO Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial ePRO Solutions
TypeSubscription Recurring
Description

Services for clinical trials and prospective observational studies, helping sponsors and CROs optimize study execution, ensure quality and compliance, and generate evidence through innovative ePRO tools.

naruhealthcare.com
2Retrospective RWE Studies
TypeSubscription Recurring
Description

Solutions for retrospective observational studies that reduce time and costs in RWE generation through a unique high-quality data network.

naruhealthcare.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1Step PROMs
Description

An independent solution enabling real-time patient-reported outcomes collection in clinical trials, replacing paper-based processes to reduce study costs and generate richer, continuous insights.

naruhealthcare.com
+2 more records
Core offering1 text field

Naru Intelligence develops and sells software solutions for clinical trials and real-world evidence (RWE) generation, with a specialization in oncology. Its core offering includes Step PROMs, an electronic Patient-Reported Outcomes (ePRO) platform that replaces paper-based data collection in clinical trials, and Step Oncology, a specialized oncology platform for structured clinical data capture combined with the RWEvolution European multi-center hospital network for continuous RWE generation. The portfolio also includes Step Proactive, a CE-marked certified patient monitoring medical device.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 96% patient adherence to ePRO questionnaires
+3 more records
Product overview1 text field

Naru Intelligence offers a unified platform architecture centered on Real-World Evidence generation for clinical research and oncology. The portfolio consists of Step PROMs (ePRO solution for prospective clinical trials), Step Oncology (core platform for structured oncology data capture), and RWEvolution (European multi-center initiative connecting hospital networks for continuous RWE generation). Step Oncology integrates four sub-products: Step Proactive (CE-marked monitoring device), patient mobile app, evidence generation tools, and analytics dashboard. The products share a common technological infrastructure enabling structured data capture from origin, continuous PRO collection, and integrated analytics across clinical and real-world settings.

Product and service1 record
1Step PROMs
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1European Collaborating Hospitals (RWEvolution Network)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Multicentric European hospital network collaborating in the RWEvolution initiative for generating real-world oncology evidence. Hospitals use Step Oncology technology to capture structured data from origin without modifying clinical workflows.

naruhealthcare.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

ObvioHealth is a digital health company offering ePRO and decentralized trial solutions, with comparable customer base (pharma sponsors and CROs) and overlapping product scope to Step PROMs.

TypeDirect peer
Description

Veeva offers a clinical trial software suite including ePRO, EDC, and CTMS that competes with Naru's Step PROMs and broader clinical trial offerings for sponsor and CRO customers.

TypeEmerging player
Description

THREAD provides a decentralized clinical trial platform with eCOA/ePRO capabilities, competing in the same emerging digital-PRO category as Naru but with a DCT-first orientation.

TypeEmerging player
Description

Castor offers an eCRF and ePRO platform aimed at clinical trials, comparable in scale and target market to Naru, with a focus on accessible, modular clinical data capture.

TypeBroad incumbent
Description

Flatiron Health (a Roche subsidiary) is a leading oncology-specific real-world evidence and EHR-data platform. It competes with Step Oncology and RWEvolution for oncology RWE generation.

TypeBroad incumbent
Description

IQVIA is a global CRO and real-world evidence powerhouse that competes across the full stack — ePRO, RWE analytics, oncology evidence — that Naru serves, but at vastly greater scale.

TypeDirect peer
Description

Medidata is the leading enterprise eCOA/ePRO platform used by most large pharmaceutical sponsors and CROs globally. It is a direct competitor to Step PROMs in clinical trial electronic patient-reported outcomes.

TypeDirect peer
Description

Clario provides eCOA, imaging, and endpoint technology for clinical trials, including a dedicated ePRO solution that competes with Naru for sponsor and CRO contracts.

TypeDirect peer
Description

Signant Health (formed from CRF Health and Bracket) is a specialist eCOA/ePRO provider focused on patient-centric clinical outcomes, directly comparable to Naru's Step PROMs offering.

TypeDirect peer
Description

YPrime is an eCOA and IRT specialist that offers ePRO solutions for clinical trials, comparable to Step PROMs in functionality and target customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Naru Intelligence

Clinical Trial Technology / ePRO Softwarenaruintelligence.com

Naru Intelligence is a Spanish healthtech software company building ePRO and Real-World Evidence platforms for pharmaceutical sponsors, CROs, and European hospitals, with core offerings including Step PROMs, Step Oncology, Step Proactive (CE-marked), and the RWEvolution multi-center oncology network.

What Naru Intelligence does

Naru Intelligence Solutions S.L. is a Spanish healthtech software company founded in 2016 and headquartered in Donostia-San Sebastián, operating with 11–50 employees. The company builds software and connected data infrastructure for clinical research, with two interlocking business lines: prospective ePRO (electronic Patient-Reported Outcomes) tools for clinical trials and observational studies, and retrospective Real-World Evidence (RWE) generation through a network of European hospitals. Its core products include Step PROMs (a real-time ePRO data collection platform), Step Oncology (a specialized oncology platform integrating patient monitoring, a prescription mobile app, evidence generation, and analytics), Step Proactive (a CE-marked patient monitoring medical device), and RWEvolution (a multi-center European program generating oncology RWE through a shared technology framework across partner hospitals).

The company targets three primary customer segments: pharmaceutical sponsors running clinical trials, Contract Research Organizations (CROs), and hospitals and oncology centers participating in the RWEvolution network. Revenue mechanics are subscription/recurring-based, delivered through a quote-based B2B sales model with no publicly disclosed pricing. Naru differentiates on data quality and adherence — reporting 96% patient adherence to ePRO questionnaires, 98% on-time completion, and 24 months of sustained adherence — alongside its CE-marked monitoring device and continuous data capture from the point of origin.

The business model relies on direct sales engagement and is regionally concentrated in Spain and broader Europe. Capital structure is private (Sociedad Limitada), supported by non-dilutive public funding including HAZITEK R&D grants (co-financed by Gobierno Vasco and FEDER 2021–2027), CDTI Innovación's Innvierte co-investment program, and ENISA innovation financing. No private venture funding rounds or revenue figures are disclosed in available sources.

Naru Intelligence firmographics

Firmographics
Name
Naru Intelligence
Legal name
NARU INTELLIGENCE SOLUTIONS S.L.
Website
https://naruintelligence.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Naru Intelligence is a Spanish healthtech software company building ePRO and Real-World Evidence platforms for pharmaceutical sponsors, CROs, and European hospitals, with core offerings including Step PROMs, Step Oncology, Step Proactive (CE-marked), and the RWEvolution multi-center oncology network.
Ownership category
akta.pro rank

Naru Intelligence industry classification

Industry
Product category
Clinical Trial Technology / ePRO Software
NAICS
Software Publishers (513210), Other Scientific and Technical Consulting Services (541690)
SIC
Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLACAOAM
Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
SECONDARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • Clinical trial ePRO software
  • Patient-reported outcomes platform
  • Real-world evidence generation
  • Oncology clinical data capture
  • Digital health technology

Where Naru Intelligence is headquartered

Location

Headquarters

HQ city
Donostia-san Sebastián
HQ country
Spain
HQ region
Europe

Offices1 record

Markets served

Naru Intelligence business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Clinical Trial ePRO Solutions: Services for clinical trials and prospective observational studies, helping sponsors and CROs optimize study execution, ensure quality and compliance, and generate evidence through innovative ePRO tools.
  2. Retrospective RWE Studies: Solutions for retrospective observational studies that reduce time and costs in RWE generation through a unique high-quality data network.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Naru Intelligence product offering

Product offering

Core offering

Naru Intelligence develops and sells software solutions for clinical trials and real-world evidence (RWE) generation, with a specialization in oncology. Its core offering includes Step PROMs, an electronic Patient-Reported Outcomes (ePRO) platform that replaces paper-based data collection in clinical trials, and Step Oncology, a specialized oncology platform for structured clinical data capture combined with the RWEvolution European multi-center hospital network for continuous RWE generation. The portfolio also includes Step Proactive, a CE-marked certified patient monitoring medical device.

Product overview

Naru Intelligence offers a unified platform architecture centered on Real-World Evidence generation for clinical research and oncology. The portfolio consists of Step PROMs (ePRO solution for prospective clinical trials), Step Oncology (core platform for structured oncology data capture), and RWEvolution (European multi-center initiative connecting hospital networks for continuous RWE generation). Step Oncology integrates four sub-products: Step Proactive (CE-marked monitoring device), patient mobile app, evidence generation tools, and analytics dashboard. The products share a common technological infrastructure enabling structured data capture from origin, continuous PRO collection, and integrated analytics across clinical and real-world settings.

Differentiator

Problem solved

Functional benefit

Brands

  • Step PROMs: An independent solution enabling real-time patient-reported outcomes collection in clinical trials, replacing paper-based processes to reduce study costs and generate richer, continuous insights.
  • Step Oncology
  • RWEvolution

Products and services

  • Step PROMs

Quantifiable outcome

  • 96% patient adherence to ePRO questionnaires
  • +3 more outcomes

Companies that use Naru Intelligence

Customer profile

Segments3 records

Ideal customer profiles3 records

Naru Intelligence technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Naru Intelligence partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • European Collaborating Hospitals (RWEvolution Network)coreStrategic or Co-development PartnerMulticentric European hospital network collaborating in the RWEvolution initiative for generating real-world oncology evidence. Hospitals use Step Oncology technology to capture structured data from origin without modifying clinical workflows.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Naru Intelligence competitors and assessment

Company assessment

Emerging players

  • ObvioHealth: ObvioHealth is a digital health company offering ePRO and decentralized trial solutions, with comparable customer base (pharma sponsors and CROs) and overlapping product scope to Step PROMs.
  • THREAD: THREAD provides a decentralized clinical trial platform with eCOA/ePRO capabilities, competing in the same emerging digital-PRO category as Naru but with a DCT-first orientation.
  • Castor: Castor offers an eCRF and ePRO platform aimed at clinical trials, comparable in scale and target market to Naru, with a focus on accessible, modular clinical data capture.

Direct peers

  • Veeva Systems: Veeva offers a clinical trial software suite including ePRO, EDC, and CTMS that competes with Naru's Step PROMs and broader clinical trial offerings for sponsor and CRO customers.
  • Medidata (Dassault Systèmes): Medidata is the leading enterprise eCOA/ePRO platform used by most large pharmaceutical sponsors and CROs globally. It is a direct competitor to Step PROMs in clinical trial electronic patient-reported outcomes.
  • Clario: Clario provides eCOA, imaging, and endpoint technology for clinical trials, including a dedicated ePRO solution that competes with Naru for sponsor and CRO contracts.
  • Signant Health: Signant Health (formed from CRF Health and Bracket) is a specialist eCOA/ePRO provider focused on patient-centric clinical outcomes, directly comparable to Naru's Step PROMs offering.
  • YPrime: YPrime is an eCOA and IRT specialist that offers ePRO solutions for clinical trials, comparable to Step PROMs in functionality and target customers.

Broad incumbents

  • Flatiron Health: Flatiron Health (a Roche subsidiary) is a leading oncology-specific real-world evidence and EHR-data platform. It competes with Step Oncology and RWEvolution for oncology RWE generation.
  • IQVIA: IQVIA is a global CRO and real-world evidence powerhouse that competes across the full stack — ePRO, RWE analytics, oncology evidence — that Naru serves, but at vastly greater scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Naru Intelligence social profiles

Digital presence

Naru Intelligence compliance and trust

Trust signal

Compliance1 record

Naru Intelligence financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Naru Intelligence leadership team

Management profile

Number of profiles

Naru Intelligence funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Naru Intelligence M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Naru Intelligence

What does Naru Intelligence do?

Naru Intelligence develops and sells software solutions for clinical trials and real-world evidence (RWE) generation, with a specialization in oncology. Its core offering includes Step PROMs, an electronic Patient-Reported Outcomes (ePRO) platform that replaces paper-based data collection in clinical trials, and Step Oncology, a specialized oncology platform for structured clinical data capture combined with the RWEvolution European multi-center hospital network for continuous RWE generation. The portfolio also includes Step Proactive, a CE-marked certified patient monitoring medical device.

Is Naru Intelligence a public or private company?

Naru Intelligence is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Naru Intelligence founded?

Naru Intelligence was founded in 2016. It employs 11 to 50 people.

Where is Naru Intelligence based?

Naru Intelligence is headquartered in Donostia-san Sebastián, Spain, in the Europe region.

How does Naru Intelligence make money?

Two revenue lines are on record. Clinical Trial ePRO Solutions are the primary driver. The others are retrospective RWE Studies.

Who are Naru Intelligence's main competitors?

Emerging players on record are ObvioHealth, THREAD and Castor. Direct peers are Veeva Systems, Medidata (Dassault Systèmes), Clario, Signant Health and YPrime. Broad incumbents are Flatiron Health and IQVIA.

Does Naru Intelligence have an API?

No public API is recorded for Naru Intelligence.

What industry is Naru Intelligence in?

Naru Intelligence's product category is Clinical Trial Technology / ePRO Software. Its primary akta.pro industry code is HLACAOAM, Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms, with a secondary code of BPAHALAN, Healthcare Outcomes & Real-World Evidence (RWE) Analytics. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales